Showing results (161-170 of 179) with videos related to
Sort By:
Pageof 18
Diabetes, Obesity & Metabolism|May 11, 2026
Gold and Clarke Questionnaires Identify Different People With Insulin-Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo-METRICS StudyVaios Koutroukas, Jonah Thomas, Gilberte Martine-Edith, et al.Diabetologia|May 25, 2024
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trialsJoseph Mellor, Dmitry Kuznetsov, Simon Heller, et al.Journal of Diabetes Science and Technology|September 6, 2023
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.Cardiovascular Diabetology|October 1, 2025
Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical trialPuriya Daniel Würtz Yazdanfard, Kathrine Kold Sørensen, Bochra Zareini, et al.Danish Medical Journal|August 18, 2020
Characteristics and early outcomes of patients hospitalised for COVID-19 in North Zealand, DenmarkMaria Elisabeth Lendorf, Mogens Karsbøl Boisen, Peter Lommer Kristensen, et al.Diabetes Technology & Therapeutics|April 25, 2022
Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.Diabetes, Obesity & Metabolism|February 7, 2023
Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Peter Lommer Kristensen, et al.Diabetic Medicine : a Journal of the British Diabetic Association|May 18, 2024
Associations of clinical, psychological, and sociodemographic characteristics and ecological momentary assessment completion in the 10-week Hypo-METRICS study: Hypoglycaemia MEasurements ThResholds and ImpaCtSNatalie Zaremba, Gilberte Martine-Edith, Patrick Divilly, et al.Diabetic Medicine : a Journal of the British Diabetic Association|December 31, 2025
User evaluation of the Hypo-METRICS app: A tool for real-time symptom reporting of hypoglycaemiaMonika Cigler, Uffe Søholm, Melanie Broadley, et al.Diabetic Medicine : a Journal of the British Diabetic Association|May 28, 2022
Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocolPatrick Divilly, Natalie Zaremba, Zeinab Mahmoudi, et al.Pageof 18